Scientific Sessions 2025  /  I Ordered Genetic Testing: Now What?  /  Can deep clinical phenotyping resolve uncertainty for my patient?
Logo

American Heart Association

  56
  0

Final ID:

Can deep clinical phenotyping resolve uncertainty for my patient?

  • Arbustini, Eloisa  ( Fond. IRCCS Policlinico San Matteo , Pavia , Italy )
  • Ware, James  ( Imperial College London , London , United Kingdom )
  • Elliott, Perry  ( University College London , London , United Kingdom )
  • Day, Sharlene  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Eloisa Arbustini: DO NOT have relevant financial relationships | James Ware: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers-Squibb:Active (exists now) ; Ownership Interest:Saturnus Bio:Active (exists now) ; Advisor:Health Lumen; Tenaya Therapeutics; Solid Biosciences; Saturnus Bio:Active (exists now) | Perry Elliott: DO have relevant financial relationships ; Consultant:Pfizer:Active (exists now) ; Consultant:Amicus:Active (exists now) ; Speaker:Chiesi:Active (exists now) ; Speaker:Amicus:Active (exists now) ; Advisor:Solid:Active (exists now) ; Consultant:Forbion:Active (exists now) ; Consultant:Affinia:Active (exists now) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:BMS:Past (completed) | Sharlene Day: DO have relevant financial relationships ; Consultant:Lexicon Pharmaceuticals:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Consultant:Solid Biosciences:Active (exists now) ; Advisor:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Lexicon Pharmaceuticals:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

I Ordered Genetic Testing: Now What?

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
What do I do with all this uncertainty?

Hespe Sophie, Pereira Naveen, Day Sharlene, Ezekian Jordan

Exploring the Interaction of Risk Factors with Monogenic/Oligogenic Diseases

Arora Pankaj, Martinez Hugo

More abstracts from these authors:
Leveraging polygenic risk scores in HCM: Is more the merrier?

Ware James

Gene Therapy Strategies, Advantages, and Pitfalls

Helms Adam, Elliott Perry, Giacca Mauro

You have to be authorized to contact abstract author. Please, Login
Not Available